Bioretec Oy (HEL:BRETEC)
0.0250
-0.0008 (-3.10%)
At close: Oct 7, 2026
Bioretec Oy Earnings Call Transcripts
Fiscal Year 2025
-
2025 was a transformative year with leadership changes, strategic resets, and strong regulatory wins. U.S. direct sales grew over 60% quarter-over-quarter, but total revenue dipped due to distribution model changes and one-off items. Focus remains on commercial growth and capital strengthening.